An interdisciplinary team of three Virginia Tech faculty members affiliated with the Macromolecules Innovation Institute has created a drug delivery system that could radically expand cancer treatment options.

The conventional cancer treatment method of injecting nanoparticle drugs into the bloodstream results in low efficacy. Due to the complexities of the human body, very few of those nanoparticles actually reach the cancer site, and once there, there’s limited delivery across the cancer tissue.

The new system created at Virginia Tech is known as Nanoscale Bacteria-Enabled Autonomous Drug Delivery System (NanoBEADS). Researchers have developed a process to chemically attach nanoparticles of anti-cancer drugs onto attenuated bacteria cells, which they have shown to be more effective than the passive delivery of injections at reaching cancer sites.

NanoBEADS has produced results in both in vitro (in tumor spheroids) and in vivo (in living mice) models showing up to 100-fold improvements in the distribution and retention of nanoparticles in cancerous tissues.

Read more at nanowerk.com

Image Credit:    Virginia Tech

News This Week

Watch Elon Musk’s Neuralink presentation

Electric vehicles, rockets... and now brain-computer interfaces. Elon Musk's newest venture, Neuralink, aims to bridge the gap between humans and artificial intelligence by implanting tiny chips that can link up to the brain. [...]

Ethics in the Age of Artificial Intelligence

Digital information technology has made information readily accessible to practically anyone, anytime and anywhere. This has had a profound effect in shaping all aspects of our society from industrial manufacturing, to distribution, to the [...]